title: Non-Hodgkin's ovarian lymphoma during adolescence: report of two cases.
abstract: OBJECTIVE
  To present two cases of non-Hodgkin's ovarian lymphoma during adolescence.
  
  
  METHODS
  Follow up of the patients. Report of diagnostic and therapeutic approaches.
  
  
  METHODS
  Division of Pediatric and Adolescent Gynecology and Corrective Gynecological Surgery, University of Athens (Athens, Greece).
  
  
  METHODS
  Laparotomy and chemotherapy. RESULTS AND MAIN OUTCOME: Three- and five-year survival rates.
  
  
  CONCLUSIONS
  Ovarian lymphoma constitutes a rare entity with guarded prognosis. Selective surgery and chemotherapy constitute the treatment of choice.
authors.affiliation: First Department of Obstetrics and Gynecology, University of Athens, Alexandra Hospital, Greece.
authors.forename: G K
authors.initials: GK
authors.lastname: Creatsas
authors.forename: E A
authors.initials: EA
authors.lastname: Hassan
authors.forename: E K
authors.initials: EK
authors.lastname: Deligeoroglou
authors.forename: S G
authors.initials: SG
authors.lastname: Markaki
authors.forename: S P
authors.initials: SP
authors.lastname: Michalas
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002051:Burkitt Lymphoma / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D016393:Lymphoma, B-Cell / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D008727:Methotrexate / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D011241:Prednisone; D008727:Methotrexate